0000899243-22-025479.txt : 20220706
0000899243-22-025479.hdr.sgml : 20220706
20220706181601
ACCESSION NUMBER: 0000899243-22-025479
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220701
FILED AS OF DATE: 20220706
DATE AS OF CHANGE: 20220706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YVER ANTOINE
CENTRAL INDEX KEY: 0001861878
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40445
FILM NUMBER: 221070053
MAIL ADDRESS:
STREET 1: C/O CENTESSA PHARMACEUTICALS PLC
STREET 2: D. HODGKIN BLDG, BABRAHAM RSRCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3FH
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Centessa Pharmaceuticals plc
CENTRAL INDEX KEY: 0001847903
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3RD FLOOR
STREET 2: 1 ASHLEY ROAD
CITY: ALTRINCHAM, CHESHIRE
STATE: X0
ZIP: WA14 2DT
BUSINESS PHONE: 44 7391 789784
MAIL ADDRESS:
STREET 1: 3RD FLOOR
STREET 2: 1 ASHLEY ROAD
CITY: ALTRINCHAM, CHESHIRE
STATE: X0
ZIP: WA14 2DT
FORMER COMPANY:
FORMER CONFORMED NAME: Centessa Pharmaceuticals Ltd
DATE OF NAME CHANGE: 20210224
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-01
0
0001847903
Centessa Pharmaceuticals plc
CNTA
0001861878
YVER ANTOINE
C/O CENTESSA PHARMACEUTICALS PLC
3RD FL., 1 ASHLEY RD, ALTRINCHAM
CHESHIRE
X0
WA14 2DT
UNITED KINGDOM
0
1
0
0
EVP & Chairman of Development
Ordinary Shares
2022-07-01
4
S
0
9100
5.0326
D
730597
D
Ordinary Shares
2022-07-01
4
A
0
100000
0.00
A
830597
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted shares and does not represent a discretionary trade by the Reporting Person.
The shares reported in this transaction represent Restricted Share Units ("RSUs") issued under the Centessa Pharmaceuticals plc Amended and Restated 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one Ordinary Share of the Issuer. The RSUs shall vest and be settled in 10 equal quarterly instalments with the first such quarterly vesting being on September 30, 2022.
/s/ Marella Thorell, attorney-in-fact
2022-07-06